Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

106
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
106
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

239
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
239
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

57
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
57
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

354
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
354
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

47
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
47
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

278
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
278

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Heterogeneous domain adaptation survival analysis with partially observed outcomes via dictionary learning and distribution alignment.

Journal of biomedical informatics·2026
Same author

Molecular mechanism leading to human coronary atherosclerosis assessed by proteomic analysis and RNA sequences.

European heart journal·2026
Same author

Mechanical circulatory support as a bridge to cancer therapy in patients with end stage heart failure: a single center experience.

Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs·2026
Same author

Mental Health and Substance Use Disorders in Advanced Heart Failure Patients Undergoing VAD Implantation and Cardiac Transplantation: How Much do We Know?

Current cardiology reviews·2026
Same author

Machine Learning Models for Posttransplant Lymphoproliferative Disorder (PTLD) Risk Prediction in Thoracic Transplantation.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
Same author

Determining Causes of Insulin-Induced Hypoglycemia Using an Electronic-Based Trigger.

American journal of medical quality : the official journal of the American College of Medical Quality·2026

相关实验视频

Updated: May 12, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

可扩展的贝叶斯非参数方法用于使用来自异质人群的大规模数据进行临床风险预测.

Ning Dong, Nandini Nair, Dongping Du

    IEEE journal of biomedical and health informatics
    |May 7, 2025
    PubMed
    概括

    这项研究引入了一个可扩展的贝叶斯框架来分析大型临床数据集,通过对具有相似风险概况的患者进行集群来提高风险预测的准确性. 该方法有效地处理患者异质性和复杂的数据模式.

    科学领域:

    • 计算统计的计算统计.
    • 生物统计学 生物统计学
    • 机器学习在医疗保健中的应用

    背景情况:

    • 大规模的临床数据集为增强风险预测提供了潜力,但由于患者异质性和数据动态,这也带来了挑战.
    • 现有的风险建模技术与医疗保健中常见的复杂,重叠的数据分布作斗争.
    • 比如迪里克莱特过程混合模型 (DPMM) 这样的贝叶斯非参数方法适合这样的数据,但对于大数据集来说计算密集.

    研究的目的:

    • 从大型临床数据集中开发一个可扩展的框架来构建迪里克莱特过程混合模型 (DPMMs).
    • 在风险预测中的大数据应用中解决DPMM的计算局限性.
    • 通过考虑患者异质性,提高风险预测模型的准确性和效率.

    主要方法:

    • 通过将大型数据集分成较小的子集来开发一个可扩展的框架,用于并行DPMM学习.
    • 一个重新聚焦的伪巴里中心被用来近似整个数据集的后密度.
    • 设计了一种新的算法,用于从具有不同组件数的子集后部进行一致的集群.

    主要成果:

    • 与Cox比例危险和随机生存森林相比,拟议的框架在植入左心室辅助器件后预测心力衰竭患者存活率的准确性提高了.
    • 该方法有效地将患者分为不同的风险小组,考虑到重叠的后部混合物.

    更多相关视频

    Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
    07:31

    Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

    Published on: May 15, 2020

    6.9K
    Establishing a Competing Risk Regression Nomogram Model for Survival Data
    04:57

    Establishing a Competing Risk Regression Nomogram Model for Survival Data

    Published on: October 23, 2020

    10.0K

    相关实验视频

    Last Updated: May 12, 2025

    An R-Based Landscape Validation of a Competing Risk Model
    05:37

    An R-Based Landscape Validation of a Competing Risk Model

    Published on: September 16, 2022

    2.0K
    Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
    07:31

    Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

    Published on: May 15, 2020

    6.9K
    Establishing a Competing Risk Regression Nomogram Model for Survival Data
    04:57

    Establishing a Competing Risk Regression Nomogram Model for Survival Data

    Published on: October 23, 2020

    10.0K
  • 通过模拟验证和临床案例研究证实了该框架的有效性.
  • 结论:

    • 开发的可扩展DPMM框架为分析大型异质临床数据集提供了有效的方法.
    • 这种方法通过适应性聚类患者和建模重叠的风险概况来提高风险预测的准确性.
    • 该框架提供了一个计算可行的解决方案,用于将先进的贝叶斯方法应用于现实世界的临床数据挑战.